Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome

Journal of Clinical Immunology

Volumn 20, Issue 4, 2000, Pages 287-293

  Hermitte, Laurence ^a   Martin Moutot, Nicole ^b   Boucraut, Jose ^a   Barone, Roselyne ^a   Atlan Gepner, Catherine ^a   Seagar, Michaël ^b   Pouget, Jean ^c   Kleisbauer, Jean Pierre ^d   Couraud, François ^b   Vialettes, Bernard ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

^c TIMONE HOSPITAL   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Glutamic acid decarboxylase; IA 2 tyrosine phosphatase; Lambert Eaton myasthenic syndrome; Small cell lung carcinoma

Indexed keywords

GLUTAMATE DECARBOXYLASE; PROTEIN TYROSINE PHOSPHATASE;

ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CROSS REACTION; EATON LAMBERT SYNDROME; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LUNG SMALL CELL CANCER; MOLECULAR RECOGNITION; MYASTHENIA GRAVIS; NEUROSECRETORY CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL;

EID: 0033856251     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006619820040     Document Type: Article

References (36)

1. Pancreatic development and maturation of the islet β cell. Studies of pluripotent islet cultures
2. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
3. Aromatic L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme β cell autoantigen
4. ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules
5. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma
6. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type I diabetes
7. Evaluation of ICA512Ab in combination with other islet cell autoantibodies at the onset of IDDM
8. IA-2 antibodies - A sensitive marker of IDDM with clinical onset in childhood and adolescence
9. The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome patients
10. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test
11. Lambert-Eaton myasthenic syndrome: Clinical diagnosis, immune-mediated mechanisms, and update on therapies
12. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane actives zones
13. Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: Complement independence and EMG abnormalities
14. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes
15. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral slerosis
16. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis
17. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum
18. Immunological aspects of demyelinating diseases
19. Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study
20. Systemic autoimmune features and multiple sclerosis. A 5-year follow-up study
21. The Lambert-Eaton myasthenic syndrome: A review of 50 cases
22. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
23. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis
24. Islet autoantibody markers in IDDM: Risk assessment strategies yielding high sensitivity
25. Diverging evolution of anti-GAD and anti-IA-2 antibodies in long-standing diabetes mellitus as a function of age at onset: No association with complications
26. Interaction of complexes with P/Q-type calcium channel in rat cerebellar synaptosomes
27. Glutamic acid decarboxylase in cerebrospinal fluid in infancy and childhood part II. Glutamic acid decarboxylase activity in cerebrospinal fluid of children with neurological diseases
28. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome
29. Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements
30. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type 1 recognize different epitopes
31. 65A, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus
32. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome
33. Islet cell cytoplasmic reactivity to glutamate decarboxylase in insulin-dependent diabetes
34. 2+ channels exposed to serum from patients with type I diabetes
35. IA-2, a transmembrane protein tyrosine phosphatase, is expressed in human lung cancer cell lines with neuroendocrine phenotype
36. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers and chromosomal characteristics of permanent human cell lung cancer cell lines